Pharmacological targeting of IRE1 in cancer by Pelizzari Raymundo, D, Doultsinos, D, Guillory, X, Carlesso, A, Eriksson, LA, Chevet, E

Peptidomimetic‐based identification of FDA approved compounds inhibiting IRE1 activity by Doultsinos, D, Carlesso, A, Chintha, C, Paton, JC, Paton, AW, Samali, A, Chevet, E, Eriksson, LA